Atrás
40
Rango del Día
$264.35
$270.59
Rango de 52 Semanas
$209.38
$293.72
Volumen
439,069
Promedio 50D / 200D
$272.78
/
$267.35
Cierre Anterior
$263.00
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 25.0 | 0.4 |
| P/B | 2.5 | 2.9 |
| ROE % | 10.5 | 3.8 |
| Net Margin % | 6.3 | 3.9 |
| Rev Growth 5Y % | 1.5 | 10.0 |
| D/E | 0.8 | 0.2 |
Puntos Clave
Revenue grew 1.52% annually over 5 years — modest growth
Earnings grew 17.49% over the past year
ROE of 10.51% — decent returns on equity
Generating 1.21B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.73%
Cash machine — converts 137.59% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
1.52%
Revenue (1Y)7.25%
Earnings (1Y)17.49%
FCF Growth (3Y)17.46%
Calidad
Return on Equity
10.51%
ROIC7.19%
Net Margin6.28%
Op. Margin10.87%
Seguridad
Debt / Equity
0.84
Current Ratio1.42
Interest Coverage6.77
Valoración
P/E Ratio
25.01
P/B Ratio2.54
EV/EBITDA18.86
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.25% | Revenue Growth (3Y) | 7.11% |
| Earnings Growth (1Y) | 17.49% | Earnings Growth (3Y) | 44.81% |
| Revenue Growth (5Y) | 1.52% | Earnings Growth (5Y) | -22.08% |
| Profitability | |||
| Revenue (TTM) | 13.95B | Net Income (TTM) | 876.50M |
| ROE | 10.51% | ROA | 4.77% |
| Gross Margin | 26.75% | Operating Margin | 10.87% |
| Net Margin | 6.28% | Free Cash Flow (TTM) | 1.21B |
| ROIC | 7.19% | FCF Growth (3Y) | 17.46% |
| Safety | |||
| Debt / Equity | 0.84 | Current Ratio | 1.42 |
| Interest Coverage | 6.77 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 25.01 | P/B Ratio | 2.54 |
| P/S Ratio | 1.57 | PEG Ratio | 1.28 |
| EV/EBITDA | 18.86 | Dividend Yield | 0.01% |
| Market Cap | 21.92B | Enterprise Value | 28.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B |
| Net Income | 876.50M | 746.00M | 418.00M | 1.28B | 2.38B |
| EPS (Diluted) | 10.46 | 8.84 | 4.77 | 13.96 | 24.38 |
| Gross Profit | 3.73B | 3.62B | 3.36B | 3.71B | 4.99B |
| Operating Income | 1.52B | 1.09B | 725.60M | 1.44B | 3.05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18.39B | 18.38B | 16.73B | 20.16B | 20.39B |
| Total Liabilities | 9.76B | 10.31B | 8.83B | 10.04B | 10.09B |
| Shareholders' Equity | 8.62B | 8.05B | 7.88B | 10.10B | 10.27B |
| Total Debt | 7.20B | 7.27B | 5.95B | 6.25B | 6.34B |
| Cash & Equivalents | 532.30M | 1.52B | 536.80M | 320.60M | 1.47B |
| Current Assets | 4.02B | 4.81B | 3.77B | 4.63B | 5.33B |
| Current Liabilities | 2.82B | 3.33B | 3.23B | 3.08B | 2.78B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#613 of 1024
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026